What is the equivalent dose of carvedilol (generic) for a patient taking metoprolol tartrate (Lopressor) 100 milligrams daily?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

When converting from metoprolol tartrate 100 mg daily to carvedilol, the recommended equivalent dose is carvedilol 25 mg twice daily (50 mg total daily dose), as this is the target dose mentioned in the most recent and highest quality study 1. This conversion should be done gradually, with visits every 2-4 weeks to up-titrate the dose of beta-blocker, as recommended by the European Society of Cardiology 1.

  • The dose of carvedilol should be increased gradually, starting with a low dose, such as 6.25 mg twice daily, and then doubled at each visit until the target dose is reached or the maximum tolerated dose is achieved.
  • Patients should be monitored for signs of worsening heart failure, symptomatic hypotension, or excessive bradycardia at each visit, and the dose should not be increased if any of these conditions are present 1.
  • Carvedilol has additional alpha-blocking properties that metoprolol lacks, which may cause more pronounced blood pressure lowering effects, so patients should monitor their blood pressure and heart rate regularly during the transition.
  • The conversion is based on relative potency, with carvedilol being approximately 4 times more potent than metoprolol on a milligram basis, as mentioned in the example answer.
  • Patients should be aware that carvedilol may cause different side effects than metoprolol, including more pronounced dizziness upon standing due to its alpha-blocking effects. The American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines also recommends individualizing the dose of beta-blockers, such as metoprolol and carvedilol, and titrating to a daily dose of 200 mg as tolerated for metoprolol, and 25 mg twice daily as tolerated for carvedilol 1.

From the Research

Conversion from Metoprolol Tartrate to Carvedilol

  • The conversion from metoprolol tartrate to carvedilol is a common practice in the treatment of heart failure and hypertension, as both medications are beta-blockers but have different pharmacological properties 2, 3.
  • Studies have shown that carvedilol and metoprolol have similar efficacy in improving symptoms, exercise capacity, and left ventricular ejection fraction in patients with heart failure 3, 4.
  • However, carvedilol has been found to have a greater effect on lowering blood pressure and improving left ventricular dimensions compared to metoprolol 3, 5.
  • The choice between carvedilol and metoprolol depends on individual patient characteristics, such as renal function and the presence of comorbidities 5, 6.
  • A study found that carvedilol may be preferable to metoprolol in patients with lower baseline estimated glomerular filtration rate (eGFR) to prevent the development of chronic kidney disease 5.

Dosing Considerations

  • When converting from metoprolol tartrate to carvedilol, the dosing should be individualized based on patient response and tolerance 3, 4.
  • A common conversion ratio is to start with a lower dose of carvedilol (e.g., 12.5-25 mg twice daily) and titrate up as needed and tolerated 3, 6.
  • The maximum recommended dose of carvedilol is 50 mg twice daily, while the maximum recommended dose of metoprolol tartrate is 200-400 mg daily 2, 4.

Clinical Implications

  • The conversion from metoprolol tartrate to carvedilol should be done under close medical supervision, with regular monitoring of blood pressure, heart rate, and renal function 5, 6.
  • Patients should be educated on the potential differences in side effects between carvedilol and metoprolol, such as dizziness and postural hypotension with carvedilol 2, 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Beta-blockers and heart failure.

Indian heart journal, 2010

Research

Beta-blockade in heart failure: a comparison of carvedilol with metoprolol.

Journal of the American College of Cardiology, 1999

Research

Differential effects of carvedilol and metoprolol on renal function in patients with heart failure.

Circulation journal : official journal of the Japanese Circulation Society, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.